Alterity Therapeutics (ATHE) Debt Ratio (2011 - 2025)

Alterity Therapeutics has reported Debt Ratio for 12 years, with the latest figure at 0.02 in Q2 2025.

• On a quarterly basis, Debt Ratio rose 102.3% year-over-year to 0.02 in Q2 2025; TTM through Jun 2025 was 0.02, a 102.3% increase from a year earlier, with the FY2025 full-year figure at 0.02, up 251.8% from the prior year.
• Debt Ratio was 0.02 for Q2 2025 at Alterity Therapeutics, up from 0.99 in the prior quarter.
• The five-year high for Debt Ratio was 33.87 in Q2 2023, with the low at 0.99 in Q2 2024.
• Average Debt Ratio over 5 years is 6.83, with a median of 0.61 recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio soared 5056.4% in 2023, then tumbled 102.92% in 2024.
• Over 5 years, Debt Ratio stood at 0.61 in 2021, then advanced by 7.22% to 0.66 in 2022, then jumped by 5056.4% to 33.87 in 2023, then sank by 102.92% to 0.99 in 2024, then surged by 102.3% to 0.02 in 2025.
• The last three Debt Ratio figures came in at 0.02 (Q2 2025), 0.99 (Q2 2024), and 33.87 (Q2 2023), per Business Quant data.